دورية أكاديمية

Current Place of SGLT2i in the Management of Heart Failure: An Expert Opinion from India.

التفاصيل البيبلوغرافية
العنوان: Current Place of SGLT2i in the Management of Heart Failure: An Expert Opinion from India.
المؤلفون: Chopra HK; Senior Consultant, Department of Cardiology, Medanta Moolchand Heart Center, Delhi, India., Nair T; Head, Department of Cardiology, PRS Hospital, Trivandrum, Kerala, India., Wander GS; Professor, Department of Cardiology, Dayanand Medical College & Hospital (DMCH); Hero DMC Heart Institute, Ludhiana, Punjab, India, Corresponding Author., Ponde CK; Consultant Cardiologist and Head, Department of Cardiology, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India., Ray S; Director, Department of Invasive Cardiology, AMRI Hospital, Kolkata, West Bengal, India., Khullar D; Chairman-Nephrology and Renal Transplant Medicine, Department of Nephrology and Renal Transplant Medicine, Max Super Speciality Hospital, Delhi, India., Nanda NC; Distinguished Professor, Department of Medicine and Cardiovascular Disease, Division of Cardiology, University of Alabama at Birmingham, Birmingham, Alabama USA., Narula J; Executive Vice President & Chief Academic Officer, University of Texas, Houston K. Lance Gould, Distinguished University Chair for Coronary Pathophysiology, Distinguished Professor of Medicine & Cardiology McGovern Medical School, Houston Texas, USA., Kasliwal RR; Chairman, Department of Clinical and Preventive Cardiology, Medanta-The Medicity, Gurugram, Haryana, India., Rana DS; Chairman, Department of Nephrology, Sir Ganga Ram Hospital, Delhi, India., Kirpalani A; Consultant Nephrologist, Bombay Hospital, Mumbai, Maharashtra, India., Sawhney JPS; Chief of Clinical and Preventive Cardiology, Chairman, Department of Cardiology, Sir Gangaram Hospital, Delhi, India., Chandra P; Chairman, Department of Interventional and Structural Heart Cardiology, Medanta-The Medicity, Gurugram, Haryana, India., Mehta Y; Director, Department of Critical Care Medicine, Medanta Institute of Critical Care Anaesthesiology, Medanta, The Medicity, Gurugram, Haryana, India., Kumar V; Principal Director and Chief of Cath Labs (Pan Max), Department of Cardiac Sciences, Max Hospital, Delhi, India., Tewari S; Professor, Department of Cardiology at SGPGIMS, Lucknow, Uttar Pradesh, India., Pancholia AK; Head of Department, Department of Clinical and Preventive Cardiology, Arihant Hospital and Research Centre, Indore, Madhya Pradesh, India., Kher V; Chairman, Department of Nephrology; Department of Kidney Transplant, Epitome Kidney Urology Institute and Lions Hospital, Delhi, India., Bansal S; Consultant in Cardiology, Professor and Head, Department of Cardiology, Vardhaman Mahavir Medical College and Safdarjung Hospital, Delhi, India., Mittal S; Senior Cardiologist, Medanta-The Medicity, Gurugram, Haryana, India., Kerkar P; Senior Consultant Interventional Cardiologist, Asian Heart Institute, Mumbai, Maharashtra, India., Sahoo PK; Interventional Cardiology, Department of Cardiology, Apollo Hospital, Bhubaneshwar, Odisha, India., Hotchandani R; Consultant, Head, Department of Nephrology, Moolchand Centre for Renal Care and Dialysis, Moolchand Hospital, Delhi, India., Prakash S; Senior Director and Head, Department of Nephrology and Renal Transplantation, BLK-Max Super Speciality Hospital, Delhi, India., Chauhan N; Senior Cardiologist, Medanta-The Medicity, Gurugram, Haryana, India., Rastogi V; Director, Department of Interventional Cardiology, Head of Advanced Heart Failure Program, Fortis Escort Heart Institute, Delhi, India., Jabir A; Senior Cardiologist and Assistant Professor, Lisie Hospital, Cochin, Kerala, India., Shanmugasundaram S; Senior Cardiologist, Billroth Hospitals, Chennai, Tamil Nadu, India., Tiwaskar M; Consultant Physician and Diabetologist, Shilpa Medical Research Centre, Mumbai, Maharashtra, India., Sinha A; Senior Consultant, Department of Cardiology, Medanta Heart Institute, Patna, Bihar, India., Gupta V; Consulting Physician, Department of Internal Medicine, Kishori Ram Hospital and Diabetes Care Centre, Bhatinda, Punjab, India., Mishra SS; Director and Senior Consultant Cardiologist, Med N Heart Clinic, Cuttack, Odisha, India., Routray SN; Professor and Head, Department of Cardiology, SCB Medical College, Cuttack, Odisha, India., Omar AK; Director, Fortis Escorts Heart Institute, Department of Non-invasive Cardiology, Delhi, India., Swami OC; Senior Vice President, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India., Jaswal A; Director, Department of Cardiac Pacing and Electrophysiology, Fortis Escorts Heart Institute, Delhi, India., Alam S; Consultant Interventional Cardiologist, Jayprabha Medanta Super Speciality Hospital, Patna, Bihar, India., Passey R; Consultant Cardiologist, Sir Ganga Ram Hospital, Delhi, India., Rajput R; Senior Consultant Cardiologist, Apollo Hospitals, Delhi, India., Paul J; Professor of Cardiology, Madras Medical College, Chennai, Tamil Nadu, India., Kapoor A; Head, Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India., Prabhakar D; Consultant Interventional Cardiologist, Ashwin Clinic, Chennai, Tamil Nadu, India., Chandra S; Chairman and Head, Department of Cardiology and Structural Heart Disease, BLK Max Super Speciality Hospital, Delhi, India., Malhotra P; Senior Professor, Department of Cardiac Anaesthesia, All India Institute of Medical Sciences, Delhi, India., Singh VP; Senior Consultant, Interventional Cardiologist, Fortis Escort Heart Institute, Delhi, India., Bansal M; Senior Cardiologist, Medanta-The Medicity, Gurugram, Haryana, India., Shah P; Assistant General Manager, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India., Jain S; Associate Vice President, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India., Bhargava M; Director of Cardiology and Interventional Cardiologist, Max Hospital, Delhi, India., Vijayalakshmi IB; Professor Emeritus, Former Head Cardiology, Shri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India., Varghaese K; Professor and Former Head, Department of Cardiology, St. John's Medical College, Bengaluru, Karnataka, India., Jain D; Professor and Former Head, Department of Cardiology, IMS, BHU, Varanasi, Uttar Pradesh, India., Goel A; Director, Interventional Cardiology, Max Super-speciality hospital, Delhi, India, India., Mehmood K; Assistant Professor, Department of Medicine and Cardiology, Icahn School of Medicine at Mount Sinai; Director, Heart Failure Program, Mount Sinai Morningside Hospital, New York, USA., Gaur N; CVTS, AIIMS Rishikesh, Rishikesh, Uttarakhand, India., Tandon R; Consultant, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India., Moorthy A; Senior Consultant Cardiologist, SIMS Hospital, Chennai, Tamil Nadu, India., George S; Senior Interventional Cardiologist & Head of Cardiology, Department of Interventional Cardiology, Jubilee Memorial Hospital, Trivandrum, Kerala, India., Katyal VK; Head of Department, Department of General Medicine, Positron Hospital; Formerly Senior Professor, Department of Medicine, Pt BD Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India., Mantri RR; Director, Department of Cardiology, Sir Ganga Ram Hospital, Delhi, India., Mehrotra R; Director and Head, Department of Non-invasive Cardiology, Max Super Speciality Hospital, Delhi, India., Bhalla D; Senior Director, Department of Nephrology and Renal Transplant, Max Super Speciality Hospital, Delhi, India., Mittal V; Senior Consultant Diabetologist and Head, Centre for Diabetes and Metabolic Diseases, Heart and Lung Institute, Delhi, India., Rao S; Senior Interventional Cardiologist, Director Cath Lab, Apollo Hospital, Indore, Madhya Pradesh, India., Jagia M; Director, Department of Anaesthesia and Critical care, Moolchand Hospital, Delhi, India., Singh H; Consultant, Critical Care Specialist, Max Super Speciality Hospital, Ghaziabad, Uttar Pradesh, India., Awasthi S; Consultant, Critical Care Specialist, Moolchand Hospital, Delhi, India., Sattur A; Director of Cath Lab HCG, Suchiraya Hospital, Hubli, Karnataka, India., Mishra R; Consultant Cardiologist, Indraprastha, Apollo Hospital, Delhi, India., Pandey A; Senior Consultant Cardiologist, Department of Cardiology, Kailash Deepak Hospital, Delhi, India., Chawla R; Senior Consultant Diabetologist and Director of North Delhi Diabetes and Cardiac Centre, Delhi, India., Jaggi S; Consultant Diabetologist and Head, Dr Mohan Diabetes Specialities Centre, Delhi, India., Sehgal B; Senior Consultant, Nephrology, Shree Balaji Action Medical Institute, Delhi, India., Sehgal A; Head of Department and Chief Interventional Cardiologist, Yeshoda Super Speciality Hospital, Ghaziabad, Uttar Pradesh, India., Goel N; Director and HOD, Department of Cardiology and HF, Fortis Shalimar Bagh Hospital, Delhi, India., Gupta R; Interventional Cardiologist, Max Super Speciality Hospital, Delhi, India., Kubba S; Director and Unit Head, Department of Cardiology, Dharmshila Narayana Superspeciality Hospital, Delhi, India., Chhabra A; Interventional Cardiologist, Fortis Hospital, Delhi, India., Bagga S; Senior Cardiologist, Medanta-The Medicity, Gurugram, Haryana, India., Shastry NR; Consultant Cardiologist, Medanta Moolchand Heart Center, Delhi, India.
المصدر: The Journal of the Association of Physicians of India [J Assoc Physicians India] 2024 Jan; Vol. 72 (1), pp. 63-73.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Association of Physicians of India Country of Publication: India NLM ID: 7505585 Publication Model: Print Cited Medium: Print ISSN: 0004-5772 (Print) Linking ISSN: 00045772 NLM ISO Abbreviation: J Assoc Physicians India Subsets: MEDLINE
أسماء مطبوعة: Publication: Bombay : Association of Physicians of India
Original Publication: Bombay [1953?]-
مواضيع طبية MeSH: Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Heart Failure*/drug therapy , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications, Humans ; India
مستخلص: Heart failure (HF) is a global health concern that is prevalent in India as well. HF is reported at a younger age in Indian patients with comorbidity of type 2 diabetes (T2DM) in approximately 50% of patients. Sodium-glucose cotransporter-2 inhibitors (SGLT2i), originally approved for T2DM, are new guideline-recommended and approved treatment strategies for HF. Extensive evidence highlights that SGLT2i exhibits profound cardiovascular (CV) benefits beyond glycemic control. SGLT2i, in conjunction with other guideline-directed medical therapies (GMDT), has additive effects in improving heart function and reducing adverse HF outcomes. The benefits of SGLT2i are across a spectrum of patients, with and without diabetes, suggesting their potential place in broader HF populations irrespective of ejection fraction (EF). This consensus builds on the updated evidence of the efficacy and safety of SGLT2i in HF and recommends its place in therapy with a focus on Indian patients with HF.
(© Journal of the Association of Physicians of India 2024.)
المشرفين على المادة: 0 (Sodium-Glucose Transporter 2 Inhibitors)
تواريخ الأحداث: Date Created: 20240513 Date Completed: 20240513 Latest Revision: 20240709
رمز التحديث: 20240710
DOI: 10.59556/japi.71.0440
PMID: 38736076
قاعدة البيانات: MEDLINE
الوصف
تدمد:0004-5772
DOI:10.59556/japi.71.0440